POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

NCT01051817 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis
RRMS

Interventions

DRUG: AIN457
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals